Dr. Reddy’s (NYSE: RDY) schedules June 2026 investor conferences in Mumbai and Hyderabad

Rhea-AI Filing Summary

Dr. Reddy’s Laboratories Limited filed a Form 6-K to inform markets that its management will participate in upcoming investor conferences. The company plans a group investor meet organized by ICICI Securities in Mumbai on June 9, 2026 from 10:00 to 17:00 IST, and another group meeting organized by Macquarie in Hyderabad on June 10, 2026 from 12:00 to 13:00 IST. The company notes that these schedules may change due to exigencies on the part of investors or the company.

Key Figures

ICICI Securities meet date: June 9, 2026 ICICI meet timing: 10:00 - 17:00 IST Macquarie meet date: June 10, 2026 +1 more

4 metrics

ICICI Securities meet date June 9, 2026 Group investor meeting in Mumbai

ICICI meet timing 10:00 - 17:00 IST Mumbai group investor session

Macquarie meet date June 10, 2026 Group investor meeting in Hyderabad

Macquarie meet timing 12:00 - 13:00 IST Hyderabad group investor session

Key Terms

Form 6-K, foreign private issuer, investor conference, group meet

4 terms

Form 6-K regulatory

"SECURITIES AND EXCHANGE COMMISSION Form 6-K REPORT OF FOREIGN PRIVATE ISSUER"

A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.

foreign private issuer regulatory

"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT RULE 13A-16 OR 15D-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

investor conference financial

"management will be participating in the following investor conference with single institution(s)/ investor groups"

group meet financial

"Nature of meet | Timing 09.06.2026 | ICICI Securities | Mumbai | In-Person | Group Meet"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

June, 2026

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

 (Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x                                       Form 40-F   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ______

Note:  Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ______

Note:  Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨                                       No   x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number		Description of Exhibits
99.1		Intimation dated June 3, 2026

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED (Registrant)
Date: June 3, 2026	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

3

Exhibit 99.1

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India   CIN: L85195TG1984PLC004507   Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.com

June 3, 2026

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)

BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings

This is to inform that the Company’s management will be participating in the following investor conference with single institution(s)/ investor groups:

Date	Organized by	Location	Meeting mode	Nature of meet	Timing
09.06.2026	ICICI Securities	Mumbai	In-Person	Group Meet	10:00 - 17:00 IST
10.06.2026	Macquarie	Hyderabad	In-Person	Group Meet	12:00 - 13:00 IST

Please note that the schedule of the aforesaid meeting is subject to change due to any exigencies on the part of Investors / Company.

This is for your information.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

 

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

FAQ

What does Dr. Reddy’s Laboratories (RDY) disclose in this Form 6-K?

Dr. Reddy’s Laboratories discloses that its management will attend two investor conferences in June 2026. These are group meetings with institutional investors organized by ICICI Securities in Mumbai and Macquarie in Hyderabad.

When are Dr. Reddy’s (RDY) investor conferences scheduled in June 2026?

The company plans investor group meetings on June 9, 2026, and June 10, 2026. The first is a full-day session in Mumbai, and the second is a one-hour session in Hyderabad.

Who is organizing the June 2026 investor meetings for Dr. Reddy’s (RDY)?

The June 2026 investor meetings are organized by ICICI Securities and Macquarie. ICICI Securities hosts the Mumbai group meet, while Macquarie hosts the Hyderabad group meet with company management.

Where will Dr. Reddy’s (RDY) June 2026 investor conferences take place?

The investor conferences will take place in Mumbai and Hyderabad. ICICI Securities will host the Mumbai meeting, and Macquarie will host the Hyderabad meeting, both as in-person group sessions.

Can the schedule of Dr. Reddy’s (RDY) June 2026 investor meets change?

Yes, the company states the schedule is subject to change due to exigencies. Changes may arise on the part of either the investors or Dr. Reddy’s Laboratories itself.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 8.3 KB